Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

INEF · Inhibiting Nef: a novel drug target for HIV-host interactions

FP7Status: CLOSED1 January 200830 June 2011EU funding €2,470,540

Although HIV-1 Nef was originally named negative factor," it has been shown to be critical for efficient persistance of HIV-1 infected humans thus playing a major role in the progression to AIDS. Remarkably

Consortium · 9 organisations

coordinator

UNIVERSITEIT GENT

BE · €605,520

participant

HELSINGIN YLIOPISTO

FI · €449,920

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR

participant

ECOSYNTH

BE · €248,040

participant

UNIVERSITAET ULM

DE · €471,600

participant

INSTITUTES DE RECHERCHES CLINIQUES DE MONTREAL

CA

participant

UNIVERSITE DE STRASBOURG

FR · €82,180

participant

INSTITUT PASTEUR

FR · €448,920

participant

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE · €164,360

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.